Whole-Body Low-Dose Multidetector-Row CT in Multiple Myeloma: Guidance in Performing, Observing, and Interpreting the Imaging Findings.
low-dose CT
multiple myeloma
whole-body CT
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
30 Nov 2021
30 Nov 2021
Historique:
received:
09
11
2021
revised:
20
11
2021
accepted:
26
11
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
Multiple myeloma is a hematological malignancy of plasma cells usually detected due to various bone abnormalities on imaging and rare extraosseous abnormalities. The traditional approach for disease detection was based on plain radiographs, showing typical lytic lesions. Still, this technique has many limitations in terms of diagnosis and assessment of response to treatment. The new approach to assess osteolytic lesions in patients newly diagnosed with multiple myeloma is based on total-body low-dose CT. The purpose of this paper is to suggest a guide for radiologists in performing and evaluating a total-body low-dose CT in patients with multiple myeloma, both newly-diagnosed and in follow-up (pre and post treatment).
Identifiants
pubmed: 34947851
pii: life11121320
doi: 10.3390/life11121320
pmc: PMC8707516
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Immune Netw. 2017 Aug;17(4):250-260
pubmed: 28860954
Leukemia. 2010 May;24(5):1043-9
pubmed: 20376081
Skeletal Radiol. 2007 Oct;36(10):913-20
pubmed: 17492443
Nat Rev Dis Primers. 2017 Jul 20;3:17046
pubmed: 28726797
Front Oncol. 2021 Feb 24;11:601699
pubmed: 33718148
Can Assoc Radiol J. 2010 Dec;61(5):258-64
pubmed: 20189749
Blood Cancer J. 2015 Jul 31;5:e329
pubmed: 26230953
Eur J Radiol. 2013 Dec;82(12):2322-7
pubmed: 24074647
Blood Cancer J. 2017 Aug 25;7(8):e599
pubmed: 28841211
J Bone Oncol. 2013 Apr 18;2(2):59-69
pubmed: 26909272
Ann Hematol. 2019 Mar;98(3):679-689
pubmed: 30539276
AJR Am J Roentgenol. 2008 Apr;190(4):1097-104
pubmed: 18356461
Radiographics. 2010 Jan;30(1):127-42
pubmed: 20083590
Br J Radiol. 2014 Sep;87(1041):20140185
pubmed: 25004949
Mayo Clin Proc. 2003 Jan;78(1):21-33
pubmed: 12528874
Lancet Oncol. 2019 Jun;20(6):e302-e312
pubmed: 31162104
Ann Oncol. 2005 Aug;16(8):1223-31
pubmed: 15928069
Haematologica. 2021 Nov 01;106(11):2799-2812
pubmed: 34261295
Osteoporos Int. 2008 Jul;19(7):991-9
pubmed: 18180974
Semin Nucl Med. 2007 May;37(3):185-94
pubmed: 17418151
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
Br J Radiol. 2008 May;81(965):386-96
pubmed: 18440943
Skeletal Radiol. 2019 May;48(5):773-779
pubmed: 30218303
Blood Cancer J. 2018 Oct 4;8(10):95
pubmed: 30287814
Radiology. 2018 Jan;286(1):205-213
pubmed: 28799843
PLoS One. 2018 Dec 17;13(12):e0208860
pubmed: 30557373
Radiographics. 2019 Jul-Aug;39(4):1077-1097
pubmed: 31283452
Skeletal Radiol. 2022 Jan;51(1):43-58
pubmed: 34031705
AJNR Am J Neuroradiol. 2018 Sep;39(9):1584-1592
pubmed: 29348133
Eur J Radiol. 2005 May;54(2):289-97
pubmed: 15837412
Best Pract Res Clin Haematol. 2007 Dec;20(4):637-64
pubmed: 18070711
N Engl J Med. 2002 Feb 21;346(8):564-9
pubmed: 11856795
Blood. 1996 Feb 1;87(3):912-8
pubmed: 8562962
Ann N Y Acad Sci. 2016 Jan;1364:32-51
pubmed: 27002787
Pol J Radiol. 2012 Oct;77(4):45-50
pubmed: 23269936
Oncol Lett. 2017 Apr;13(4):2490-2494
pubmed: 28454425
AJR Am J Roentgenol. 2021 Mar;216(3):742-751
pubmed: 33439048
Magn Reson Imaging. 2013 Oct;31(8):1285-91
pubmed: 23290477